<b>Conclusions:</b> In conclusion, these findings establish CAV2 as a critical regulator of HNSCC progression and Cetuximab sensitivity via post-translational modulation of the PACT-PKR axis. Here, CAV2 is linked to head and neck squamous cell carcinoma.